Rocket Pharmaceuticals Inc - Warrants (02/09/2026)
RCKTW
Get informed when a big investor buys or sells
+ FollowMarket Cap$365.8M
Close$
Share Statistics
| Market cap | $365.80 Million |
|---|---|
| Enterprise Value | $340.95 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -87.96% |
|---|---|
| Return on Assets | -73.36% |
| Return on Invested Capital | -79.88% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.64 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Rocket Pharmaceuticals Inc
151 employees
CEO: Gaurav Shah